ScreenerHero
YPSNYpsomed Holding AG
SWX · CH · Healthcare · Medical Instruments & Supplies · ypsomed.com
405.00CHF-1.17%Mkt Cap: 6.08B $P/E: 24.83

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Société anonyme
$81.53BUSDP/E 30.5
BOX
Becton, Dickinson and Company
$49.98BUSDP/E 34.1
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon Inc.
$32.44BUSDP/E 55.0
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech S.A.
$20.46BUSDP/E 64.5
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$16.89BUSDP/E 40.2
SRT
Sartorius Aktiengesellschaft
$14.73BUSDP/E 69.1
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0

Key Statistics

Company
Market Cap6.08B $
Enterprise Value6.41B $
Revenue (TTM)834.27M $
Gross Profit359.06M $
Net Income (TTM)253.29M $
Revenue/Share61.31 USD
Last Price405.00 CHF
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990
Valuation
P/E (Trailing)24.83
P/E (Forward)26.91
PEG3.69
EV/EBITDA17.25
EV/Revenue7.69
P/S7.31
P/B6.87
EPS (TTM)16.30
EPS (Forward)15.10
52W Range
260.5091% of range419.50
52W High419.50 CHF
52W Low260.50 CHF
Profitability
Gross Margin43.04%
Oper. Margin26.45%
EBITDA Margin44.57%
Profit Margin30.36%
ROE29.66%
ROA16.48%
Growth
Revenue Growth-13.30%
Earnings Growth51.70%
Cash Flow & Leverage
Operating CF350.11M $
CapEx (TTM)368.76M $
FCF Margin-7.83%
FCF Yield-1.08%
Net Debt265.02M $
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity0.35
Current Ratio1.07
Quick Ratio0.73
Book Value/Sh59.15 CHF
Cash/Share2.172 CHF
Dividends
Fwd Div Rate4.400 CHF
Trail. Div Rate4.400 CHF
Div. Yield1.07%
5Y Avg Yield0.55%
Payout Ratio13.50%
Ex-Div DateJul 3, 2026
Pay DateJul 3, 2024
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)398.38 CHF
Upside (mean)-1.6%
Target Range280.00 CHF – 480.00 CHF
CHF280.00-1.6% to meanCHF480.00
# Analysts13
Ownership
Shares Out.13.15M
Float3.51M
Insiders74.53%
Institutions15.39%
Technical
SMA 50374.58 (+8.1%)
SMA 200324.98 (+24.6%)
Beta0.77
S&P 52W Chg18.16%
Avg Vol (30d)13.39K
Avg Vol (10d)13.32K
Technical Indicators
RSI (14)68.6
MACD11.3720
MACD Signal10.4927
MACD Hist.+0.8792
BB Upper417.44 CHF
BB Middle394.69 CHF
BB Lower371.94 CHF
BB Width11.53%
ATR (14)9.696 CHF
Vol Ratio (20d)1.14x